News Releases

Anixa Biosciences To Present Cchek™ Breast Cancer Data at AACR Special Conference on Tumor Immunology and Immunotherapy

November 15, 2018

Anixa Biosciences Presents Positive Data from its Artificial Intelligence Powered Liquid Biopsy for Prostate Cancer at SITC Conference

November 12, 2018

Anixa Biosciences to Present at SITC Annual Meeting

October 29, 2018

Anixa Biosciences Announces Scheduling of Pre-Sub Meeting with FDA for its Cchek™ Cancer Diagnostic Test

October 24, 2018

Moffitt Cancer Center and Anixa Biosciences Announce Completion of Pre-IND Meeting with FDA for CAR-T Therapy

October 22, 2018

Anixa Biosciences Releases Data Presented at AACR Artificial Intelligence Conference

October 17, 2018

Anixa Biosciences Files Pre-Submission and Requests Meeting with FDA Regarding Cchek™ Artificial Intelligence based Cancer Detection Technology

October 15, 2018

Anixa Biosciences Appoints Leading Researchers in Immuno-Oncology to its Scientific Advisory Board

October 11, 2018

Anixa Biosciences to Present at Artificial Intelligence Conference

October 5, 2018

ITUS Corporation Changing Company Name to Anixa Biosciences and Stock Ticker Symbol to ANIX

September 28, 2018

« Previous
1
2
3
4
5
6
7
8
9
10
...13
Next »

Latest News & Events

Oct 10, 2019

Anixa Biosciences Names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board

Read More...

Sep 23, 2019

Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek™ Prostate Cancer Study

Read More...

Sep 19, 2019

Anixa Biosciences Commences Collaboration with Potomac Urology Center on Cchek™ Prostate Cancer Study

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.